{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T17:03:16Z","timestamp":1770051796944,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Surg Oncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s13193-025-02303-x","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T23:39:19Z","timestamp":1744846759000},"page":"80-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring Microsatellite Instability in Endometrial Carcinomas: Clinicopathological Correlations and Clinical Implications\u2014A Study from North India"],"prefix":"10.1007","volume":"17","author":[{"given":"Rupali","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Badwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-8174","authenticated-orcid":false,"given":"Shashi","family":"Dhawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"2303_CR1","unstructured":"Chhikara BS, Parang K (2023) Global Cancer Statistics 2022: the trends projection analysis"},{"key":"2303_CR2","first-page":"1045","volume":"11","author":"R Takiar","year":"2010","unstructured":"Takiar R, Nadayil D, Nandakumar A (2010) Projections of number of cancer cases in India (2010\u20132020) by cancer groups. Asian Pac J Cancer Prev 11:1045\u20131049","journal-title":"Asian Pac J Cancer Prev"},{"key":"2303_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10\u201317","journal-title":"Gynecol Oncol"},{"key":"2303_CR4","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y et al. (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497:67\u201373","DOI":"10.1038\/nature12113"},{"key":"2303_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ijc.33763","volume":"150","author":"S Zhao","year":"2022","unstructured":"Zhao S, Chen L, Zang Y, Liu W, Liu S, Teng F et al (2022) Endometrial cancer in Lynch syndrome. Int J Cancer 150:7\u201317","journal-title":"Int J Cancer"},{"key":"2303_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/00365521.2020.1766553","volume":"55","author":"I Marques-de-S\u00e1","year":"2020","unstructured":"Marques-de-S\u00e1 I, Castro R, Pita I, Dinis-Ribeiro M, Brand\u00e3o C (2020) Cancer-risk by family history and mismatch-repair mutation in Lynch syndrome. Scand J Gastroenterol 55:701\u2013705","journal-title":"Scand J Gastroenterol"},{"key":"2303_CR7","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","volume":"24","author":"D Black","year":"2006","unstructured":"Black D, Soslow RA, Levine DA, Tornos C, Chen SC, Hummer AJ et al (2006) Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. JCO 24:1745\u20131753","journal-title":"JCO"},{"key":"2303_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1807929","volume":"2020","author":"M Lorenzi","year":"2020","unstructured":"Lorenzi M, Amonkar M, Zhang J, Mehta S, Liaw KL (2020) Epidemiology of microsatellite instability high (MSI-H) and deficient mismatch repair (dMMR) in solid tumors: a structured literature review. J Oncol 2020:1\u201317","journal-title":"J Oncol"},{"key":"2303_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jamaoncol.2015.2151","volume":"1","author":"BE Howitt","year":"2015","unstructured":"Howitt BE, Shukla SA, Sholl LM, Ritterhouse LL, Watkins JC, Rodig S et al (2015) Association of polymerase e\u2013mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1. JAMA Oncol 1:1319","journal-title":"JAMA Oncol"},{"key":"2303_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","volume":"24","author":"S Hendry","year":"2017","unstructured":"Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B et al (2017) Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in melanoma, gastrointestinal tract carcinomas, non\u2013small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors. Adv Anat Pathol 24:311\u2013335","journal-title":"Adv Anat Pathol"},{"key":"2303_CR11","unstructured":"Singh N, Wong R, Tchrakian N, Allen SG, Clarke B, Gilks CB (2020) Interpretation and reporting terminology for mismatch repair protein immunohistochemistry in endometrial cancer.\u00a0British Association of Gynaecological Pathologists Guideline Document. version1.1"},{"key":"2303_CR12","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1200\/JCO.2015.63.9518","volume":"33","author":"PJ Goodfellow","year":"2015","unstructured":"Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, Broaddus RJ et al (2015) Combined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for Lynch syndrome screening in endometrial cancers from GOG210: an NRG Oncology and Gynecologic Oncology Group Study. J Clin Oncol 33:4301\u20134308","journal-title":"J Clin Oncol"},{"key":"2303_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ygyno.2009.05.026","volume":"114","author":"FJ Backes","year":"2009","unstructured":"Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H et al (2009) Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. Gynecol Oncol 114:486\u2013490","journal-title":"Gynecol Oncol"},{"key":"2303_CR14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/PGP.0000000000000099","volume":"33","author":"YL Woo","year":"2014","unstructured":"Woo YL, Cheah PL, Shahruddin SI, Omar SZ, Arends M (2014) The immunohistochemistry signature of mismatch repair (MMR) proteins in a multiethnic Asian cohort with endometrial carcinoma. Int J Gynecol Pathol 33:554\u2013559","journal-title":"Int J Gynecol Pathol"},{"key":"2303_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s41379-020-0501-8","volume":"33","author":"A Pasanen","year":"2020","unstructured":"Pasanen A, Loukovaara M, B\u00fctzow R (2020) Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma. Mod Pathol 33:1443\u20131452","journal-title":"Mod Pathol"},{"key":"2303_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12672-022-00466-5","volume":"13","author":"YE Guo","year":"2022","unstructured":"Guo YE, Liu Y, Zhang W, Luo H, Shu P, Chen G et al (2022) The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H\/MMR-D endometrial carcinomas. Discov Onc 13:12","journal-title":"Discov Onc"},{"key":"2303_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.25259\/IJMIO_17_2020","volume":"5","author":"A Sharma","year":"2020","unstructured":"Sharma A, Kamboj M, Panaych A, Gupta G, Pasricha S, Jain V et al (2020) Assessment of mismatch repair protein expression by immunohistochemistry in endometrial carcinomas with clinicopathological correlation: a study from Indian Tertiary Cancer Care Centre. IJMIO 5:101\u2013107","journal-title":"IJMIO"},{"key":"2303_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ygyno.2014.01.017","volume":"133","author":"AS Joehlin-Price","year":"2014","unstructured":"Joehlin-Price AS, Perrino CM, Stephens J, Backes FJ, Goodfellow PJ, Cohn DE et al (2014) Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables. Gynecol Oncol 133:43\u201347","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2303_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41416-022-02063-3","volume":"128","author":"HF Berg","year":"2023","unstructured":"Berg HF, Engerud H, Myrvold M et al (2023) Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value. Br J Cancer 128(3):647\u2013655","journal-title":"Br J Cancer"},{"key":"2303_CR20","first-page":"70","volume":"10","author":"D Kanopiene","year":"2015","unstructured":"Kanopiene D, Vidugiriene J, Valuckas KP, Smailyte G, Uleckiene S, Bacher J (2015) Endometrial cancer and microsatellite instability status. Open Med (Wars) 10:70\u201376","journal-title":"Open Med (Wars)"},{"key":"2303_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.tjog.2022.03.005","volume":"61","author":"JH Kim","year":"2022","unstructured":"Kim JH, Kwon BS, Kim H, Suh DH, Kim K, Kim YB et al (2022) Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer. Taiwan J Obstet Gynecol 61:415\u2013421","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2303_CR22","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/biomedicines9101385","volume":"9","author":"JHS Lee","year":"2021","unstructured":"Lee JHS, Li JJX, Chow C, Chan RCK, Kwan JSH, Lau TS et al (2021) Long-term survival and clinicopathological implications of DNA mismatch repair status in endometrioid endometrial cancers in Hong Kong Chinese women. Biomedicines 9:1385","journal-title":"Biomedicines"},{"key":"2303_CR23","doi-asserted-by":"publisher","first-page":"151558","DOI":"10.1016\/j.anndiagpath.2020.151558","volume":"47","author":"B Rekhi","year":"2020","unstructured":"Rekhi B, Menon S, Deodhar KK, Ghosh J, Chopra S, Maheshwari A (2020) Clinicopathological features of 50 mismatch repair (MMR)-deficient endometrial carcinomas, tested by immunohistochemistry: a single institutional feasibility study. India Ann Diagn Pathol 47:151558","journal-title":"India Ann Diagn Pathol"},{"key":"2303_CR24","first-page":"417","volume":"97","author":"G Maxwell","year":"2001","unstructured":"Maxwell G (2001) Favorable survival associated with microsatellite instability in endometrioid endometrial cancers. Obstet Gynecol 97:417\u2013422","journal-title":"Obstet Gynecol"},{"key":"2303_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","volume":"33","author":"K Garg","year":"2009","unstructured":"Garg K, Leitao MM, Kauff ND, Hansen J, Kosarin K, Shia J et al (2009) Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol 33:925\u2013933","journal-title":"Am J Surg Pathol"},{"key":"2303_CR26","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.21873\/anticanres.14118","volume":"40","author":"S Vagios","year":"2020","unstructured":"Vagios S, Doulgeraki T, Giannikaki E, Kavoura E, Papadimitriou C, Gakiopoulou H et al (2020) Could mismatch repair status serve as a biomarker for immunotherapy in endometrial carcinoma? Anticancer Res 40:1669\u20131676","journal-title":"Anticancer Res"},{"issue":"13","key":"2303_CR27","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.3390\/cancers16233918","volume":"16","author":"M Albert\u00ed-Valls","year":"2024","unstructured":"Albert\u00ed-Valls M, Olave S, Olom\u00ed A, Maci\u00e0 A, Eritja N (2024) Advances in immunotherapy for endometrial cancer: insights into MMR status and tumor microenvironment. Cancers. 16(13):3918","journal-title":"Cancers."},{"key":"2303_CR28","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/jpm13081260","volume":"13","author":"H Yoshida","year":"2023","unstructured":"Yoshida H, Takigawa W, Kobayashi-Kato M, Nishikawa T, Shiraishi K, Ishikawa M (2023) Mismatch repair protein expression in endometrial cancer: assessing concordance and unveiling pitfalls in two different immunohistochemistry assays. J Pers Med 13:1260","journal-title":"J Pers Med"},{"issue":"3","key":"2303_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/cncr.35030","volume":"130","author":"CJ Riedinger","year":"2024","unstructured":"Riedinger CJ, Esnakula A, Haight PJ et al (2024) Characterization of mismatch-repair\/microsatelliteinstability-discordant endometrial cancers. Cancer 130(3):385\u2013399","journal-title":"Cancer"},{"issue":"1","key":"2303_CR30","first-page":"68","volume":"45","author":"H Kaur","year":"2024","unstructured":"Kaur H, Sharma A, Bansal S et al (2024) Mismatch repair proteins evaluation in endometrial carcinoma: clinicopathological features and prognostic implications. Eur J Gynaecol Oncol 45(1):68\u201373","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"2303_CR31","first-page":"497","volume":"153","author":"A Malhotra","year":"2021","unstructured":"Malhotra A, Arora S, Singh A et al (2021) The utility of evaluating mismatch repair proteins in endometrial carcinoma: an experience from a tertiary referral centre in North India. Indian J Med Res 153(4):497\u201350529","journal-title":"Indian J Med Res"},{"key":"2303_CR32","doi-asserted-by":"crossref","unstructured":"Solanki PK, Mandolkar M, Kulkarni P (2024) A prospective study to evaluate the prevalence of microsatellite instability in endometrial carcinoma by using immunohistochemistry for mismatch repair proteins as a surrogate marker. Indian J Med Paediatr Oncol s-0043\u20131775853","DOI":"10.1055\/s-0043-1775853"},{"key":"2303_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.25259\/IJMIO_2_2022","volume":"7","author":"S Kaur","year":"2022","unstructured":"Kaur S, Nandwani M, Garg H, Aiyer HM, Aggarwal P (2022) Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: are we ready for the change? IJMIO 7:40\u201345","journal-title":"IJMIO"},{"issue":"3","key":"2303_CR34","first-page":"316","volume":"66","author":"V Reddy","year":"2023","unstructured":"Reddy V, Narayan P, Gupta V et al (2023) Analysis of patients with endometrial carcinoma using the ProMisE classifier: a pilot study from India. Indian J Pathol Microbiol 66(3):316\u2013321","journal-title":"Indian J Pathol Microbiol"}],"container-title":["Indian Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02303-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13193-025-02303-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13193-025-02303-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:20:29Z","timestamp":1770013229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13193-025-02303-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2303"],"URL":"https:\/\/doi.org\/10.1007\/s13193-025-02303-x","relation":{},"ISSN":["0975-7651","0976-6952"],"issn-type":[{"value":"0975-7651","type":"print"},{"value":"0976-6952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors certify that they have obtained the appropriate consent from the patients. The patients have given consent for clinical information to be reported in the journal. The patients understand that the name and initials will not be published. Ethical clearance was taken from the ethics committee of the institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}